Dariusz Koziorowski

Summary

Affiliation: Medical University of Silesia
Country: Poland

Publications

  1. ncbi request reprint Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients
    D Koziorowski
    Department of Neurology, Medical University of Warsaw, Warsaw, Poland
    Neurol Neurochir Pol 47:319-24. 2013
  2. doi request reprint Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease
    Dariusz Koziorowski
    Department of Neurology, Faculty of Heath Science, Medical University of Warsaw, Kondratowicza 8, 03 242 Warsaw, Poland
    Parkinsonism Relat Disord 16:136-8. 2010
  3. ncbi request reprint [Familial occurrence of FXTAS caused by premutation in the FMR1 gene]
    Dariusz Koziorowski
    Dariusz Koziorowski, Klinika Neurologii WNoZ, Warszawski Uniwersytet Medyczny, Warszawa
    Neurol Neurochir Pol 45:391-8. 2011
  4. pmc Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease
    Dorota Hoffman-Zacharska
    Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Poland
    Parkinsonism Relat Disord 19:1057-60. 2013
  5. doi request reprint Iron as a cause of Parkinson disease - a myth or a well established hypothesis?
    Andrzej Friedman
    Department of Neurology, Medical University in Warsaw, Poland
    Parkinsonism Relat Disord 15:S212-4. 2009
  6. doi request reprint Inflammatory cytokines and NT-proCNP in Parkinson's disease patients
    Dariusz Koziorowski
    Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Poland
    Cytokine 60:762-6. 2012
  7. ncbi request reprint Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease
    Dariusz Koziorowski
    Department of Neurology, The Medical University of Warsaw, Warsaw, Poland
    Mov Disord 22:1033-6. 2007
  8. ncbi request reprint ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control
    Dariusz Koziorowski
    Department of Neurology, The Medical University in Warsaw, ul Kondratowicza 8, 03 242 Warsaw, Poland
    Parkinsonism Relat Disord 13:214-8. 2007

Detail Information

Publications8

  1. ncbi request reprint Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients
    D Koziorowski
    Department of Neurology, Medical University of Warsaw, Warsaw, Poland
    Neurol Neurochir Pol 47:319-24. 2013
    ..The aim of the study was to analyze the incidence of autosomal recessive genes PARK2, PINK1, PARK7 mutations in Polish EO-PD patients...
  2. doi request reprint Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease
    Dariusz Koziorowski
    Department of Neurology, Faculty of Heath Science, Medical University of Warsaw, Kondratowicza 8, 03 242 Warsaw, Poland
    Parkinsonism Relat Disord 16:136-8. 2010
    ..Although the frequency of the PARK2 mutations in EO-PD patients according to several studies is high and has been reported in up to 50% in familial and 19% in sporadic cases, these data remain controversial...
  3. ncbi request reprint [Familial occurrence of FXTAS caused by premutation in the FMR1 gene]
    Dariusz Koziorowski
    Dariusz Koziorowski, Klinika Neurologii WNoZ, Warszawski Uniwersytet Medyczny, Warszawa
    Neurol Neurochir Pol 45:391-8. 2011
    ..Her daughter, with mild intellectual disability, was a carrier of a full mutation. Thus, in the presented family with heterogeneous clinical presentation we found 4 premutations and one full mutation in the FMR1 gene...
  4. pmc Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease
    Dorota Hoffman-Zacharska
    Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Poland
    Parkinsonism Relat Disord 19:1057-60. 2013
    ..Mutations in the α-synuclein-encoding gene SNCA are considered as a rare cause of Parkinson's disease (PD). Our objective was to examine the frequency of the SNCA point mutations among PD patients of Polish origin...
  5. doi request reprint Iron as a cause of Parkinson disease - a myth or a well established hypothesis?
    Andrzej Friedman
    Department of Neurology, Medical University in Warsaw, Poland
    Parkinsonism Relat Disord 15:S212-4. 2009
    ..This finding corresponds well to a decrease of L-ferritin concentration in parkinsonian SN and also to a difference of the size of iron core of ferritin between PD and control SN. The significance of these finding will be discussed...
  6. doi request reprint Inflammatory cytokines and NT-proCNP in Parkinson's disease patients
    Dariusz Koziorowski
    Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Poland
    Cytokine 60:762-6. 2012
    ....
  7. ncbi request reprint Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease
    Dariusz Koziorowski
    Department of Neurology, The Medical University of Warsaw, Warsaw, Poland
    Mov Disord 22:1033-6. 2007
    ..The improvement after therapy was maintained up to 4 month. The levodopa "drug holidays" with amantadine infusion is a valuable option in the therapy of advanced stages of PD...
  8. ncbi request reprint ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control
    Dariusz Koziorowski
    Department of Neurology, The Medical University in Warsaw, ul Kondratowicza 8, 03 242 Warsaw, Poland
    Parkinsonism Relat Disord 13:214-8. 2007
    ..9+/-87.7) and control (374.8+/-169.3). The decrease of L ferritin in SN in PD and ILB may suggest that the whole process of neurodegeneration starts with a higher availability of free iron, which is released from the ferritin shell...